2nd Annual Angiogenesis: New Opportunities & Solutions for Drug Development

Venue: Hyatt Regency Cambridge

Location: Cambridge, Massachusetts, United States

Event Date/Time: Sep 27, 2004 End Date/Time: Aug 28, 2004
Early Registration Date: Aug 13, 2004
Report as Spam


Antiangiogenic therapy has now matured from concept to practice. With the success of targeted agents such as Avastin, new industrial efforts are underway to widen and optimize the field of antiangiogenic agents. As oncology drug development accelerates, new indications are beginning to emerge for diseases such as ocular neovascularization and even obesity.

This 2nd Annual Conference "Angiogenesis: New Opportunities & Solutions for Drug Development" will showcase both new and promising antiangiogenic therapeutic agents, present data on the current development of agents showing the greatest clinical potential, and discuss new opportunities and challenges in successful drug development in this exciting field. Important presentations will be made by leaders from the biopharmaceutical industry, the National Institutes of Health, and university centers of excellence.